pyrroles has been researched along with Graft vs Host Disease in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Abhyankar, S; Arbushites, M; Barbour, AM; Chacon, MJ; Chen, YB; Clausen, J; Deeren, D; Ghosh, M; Giebel, S; Kwon, M; Lakshminarayanan, M; Meyers, G; Morariu-Zamfir, R; Sanz, J; Schroeder, MA; Socié, G; Vaz, CP; Volodin, L; Zeiser, R | 1 |
| Arbushites, MC; Barkey, N; Howell, MD; Liu, H; Owens, S; Paczesny, S; Pratta, M; Schroeder, MA; Socie, G | 1 |
| Brundage, KM; Bunner, P; Craig, MD; Cumpston, A; Gibson, LF; Hamadani, M; Petros, W; Remick, SC; Tse, W; Vos, JA; Wen, S | 1 |
| Furumoto, Y; Gadina, M; Ghoreschi, K; Gutermuth, J; Katz, SI; Linton, JT; O'Shea, JJ; Okiyama, N; Tsai, WL; Villarroel, VA | 1 |
| Craig, MD; Hamadani, M; Vos, JA | 1 |
| Fuji, S; Shindo, T | 1 |
| Byoun, OJ; Garmaa, N; Lee, DS; Lee, HY; Oh, K; Park, HB; Seo, MW | 1 |
| Altman, A; Kong, KF | 1 |
| Ananth, SL; Babu, YS; Banti, S; Horn, LL; Miller, PJ; Parker, CD; Sandhu, JS | 1 |
| Baker, J; Kambham, N; Negrin, RS; Steinman, L; Youssef, S; Zeiser, R | 1 |
| Athar, U; Gentile, TC | 1 |
1 review(s) available for pyrroles and Graft vs Host Disease
| Article | Year |
|---|---|
Treatment options for metastatic renal cell carcinoma: a review.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzenesulfonates; Bevacizumab; Carcinoma, Renal Cell; Graft vs Host Disease; Humans; Immunologic Factors; Indoles; Interferon-alpha; Interleukin-2; Kidney Neoplasms; Multivariate Analysis; Niacinamide; Phenylurea Compounds; Prognosis; Pyridines; Pyrroles; Randomized Controlled Trials as Topic; Risk Assessment; Signal Transduction; Sirolimus; Sorafenib; Sunitinib; Treatment Outcome | 2008 |
3 trial(s) available for pyrroles and Graft vs Host Disease
| Article | Year |
|---|---|
Efficacy and safety of itacitinib versus placebo in combination with corticosteroids for initial treatment of acute graft-versus-host disease (GRAVITAS-301): a randomised, multicentre, double-blind, phase 3 trial.
Topics: Acetonitriles; Adrenal Cortex Hormones; Double-Blind Method; Female; Graft vs Host Disease; Humans; Pyrazoles; Pyrimidines; Pyrroles; Treatment Outcome | 2022 |
A biomarker signature to predict complete response to itacitinib and corticosteroids in acute graft-versus-host disease.
Topics: Acetonitriles; Acute Disease; Adrenal Cortex Hormones; Biomarkers; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Proteomics; Pyrazoles; Pyrimidines; Pyrroles | 2022 |
Sibling donor and recipient immune modulation with atorvastatin for the prophylaxis of acute graft-versus-host disease.
Topics: Administration, Oral; Adult; Aged; Atorvastatin; Bacterial Infections; Cytokines; Feasibility Studies; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrroles; Siblings; Survival Analysis; Tissue Donors; Transplantation Immunology; Transplantation, Homologous; Treatment Outcome; Virus Diseases; Young Adult | 2013 |
7 other study(ies) available for pyrroles and Graft vs Host Disease
| Article | Year |
|---|---|
Reversal of CD8 T-cell-mediated mucocutaneous graft-versus-host-like disease by the JAK inhibitor tofacitinib.
Topics: Administration, Oral; Animals; Bone Marrow; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cell Proliferation; Chemokines; Cytokines; Dermatitis; Gene Expression Regulation; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Interleukin-2; Keratinocytes; Mice; Mice, Inbred C57BL; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles | 2014 |
Reply to S. Fuji et al.
Topics: Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Heptanoic Acids; Humans; Male; Pyrroles; Siblings; Tissue Donors | 2014 |
T-cell characterization using multicolor flow cytometry after allogeneic hematopoietic stem-cell transplantation.
Topics: Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Heptanoic Acids; Humans; Male; Pyrroles; Siblings; Tissue Donors | 2014 |
CP-690550, a Janus kinase inhibitor, suppresses CD4+ T-cell-mediated acute graft-versus-host disease by inhibiting the interferon-γ pathway.
Topics: Animals; Bone Marrow Cells; CD4-Positive T-Lymphocytes; Cell Differentiation; Cytokines; Dendritic Cells; Graft vs Host Disease; Interferon-gamma; Interleukin-2; Janus Kinase 3; Lymphocyte Activation; Lymphocyte Depletion; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Phosphorylation; Piperidines; Pyrimidines; Pyrroles; STAT3 Transcription Factor | 2010 |
PKCθ: a new target for selective immunosuppression.
Topics: Animals; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppression Therapy; Isoenzymes; Mice; Mice, Knockout; Molecular Targeted Therapy; NF-kappa B; Protein Kinase C; Protein Kinase C-theta; Protein Kinase Inhibitors; Psoriasis; Pyrroles; Quinazolines; Signal Transduction; T-Lymphocytes | 2012 |
Comparison of in vivo efficacy of BCX-1777 and cyclosporin in xenogeneic graft-vs.-host disease: the role of dGTP in antiproliferative action of BCX-1777.
Topics: Animals; Cyclosporine; Deoxyguanine Nucleotides; Dogs; Drug Therapy, Combination; Graft vs Host Disease; Growth Inhibitors; Humans; Immunosuppressive Agents; Lymphocytes; Macaca fascicularis; Mice; Mice, Inbred BALB C; Mice, SCID; Purine Nucleosides; Pyrimidinones; Pyrroles; Rats; Rats, Sprague-Dawley; Survival Rate; Transplantation, Heterologous | 2002 |
Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity.
Topics: Adoptive Transfer; Animals; Antigen Presentation; Atorvastatin; Chemoprevention; Cytokines; Graft vs Host Disease; Graft vs Leukemia Effect; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Mice; Mice, Knockout; Premedication; Pyrroles; Signal Transduction; STAT6 Transcription Factor; T-Lymphocytes; Th2 Cells | 2007 |